Neumora Therapeutic | 4:持股变动声明-高管 Pinto Joshua
Neumora Therapeutic | 4:持股变动声明-董事 Ho Maykin
Neumora Therapeutic | 4:持股变动声明-董事 Piacquad David
Neumora Therapeutic | 4:持股变动声明-董事 Halawa Alaa
Neumora Therapeutic | 4:持股变动声明-董事 Fust Matthew K
Neumora Therapeutic | 4:持股变动声明-董事 Burow Kristina
Neumora Therapeutic | 4:持股变动声明-高管 Aurora Daljit Singh
Neumora Therapeutic | 4:持股变动声明-高管 Pinto Joshua
Neumora Therapeutic | 4:持股变动声明-董事 BERNS PAUL L
Neumora Therapeutic | 4:持股变动声明-高管 Aurora Daljit Singh
Neumora Therapeutic | 4:持股变动声明-高管 Suh Carol Y.
Neumora Therapeutic | 4:持股变动声明-高管 Lenz Robert A.
Neumora Therapeutic | 4:持股变动声明-高管 Milligan Michael Lee
Neumora Therapeutic | 4:持股变动声明-高管 Gosebruch Henry O
Neumora Therapeutic | SC 13G:超过5%持股股东披露文件-Paul L Berns(5.2%)
Neumora Therapeutic | SC 13G:超过5%持股股东披露文件-SoftBank Group Corp.(5.0%),SB Global Advisers Limited(5.0%)等
Neumora Therapeutic | SC 13D/A:超过5%持股股东披露文件(修正)-ARCH Venture Fund VII, L.P.(20.9%),ARCH Venture Fund VIII Overage, L.P.(20.9%)等
Neumora Therapeutic | 4:持股变动声明-股东 ARCH Venture Partners XII, LLC
Neumora Therapeutic | 4:持股变动声明-股东 ARCH Venture Partners X, LLC
Neumora Therapeutic | 4:持股变动声明-董事 Burow Kristina
暂无数据